Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page
- Check6 days agoChange DetectedThe 403 error page was replaced by the ClinicalTrials.gov page shell, which displays an NIH transition notice but no study details.SummaryDifference2%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe study record page now renders a 403 Forbidden error, replacing the study content and navigation with a basic error page. This indicates access to the study information at this URL is blocked.SummaryDifference17%

- Check62 days agoChange DetectedRevision: v3.6.6 is now displayed, replacing the previous v3.6.5. This reflects an updated page version.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page revision stamp was updated from v3.6.4 to v3.6.5, reflecting a new release version. This change does not affect the visible content or functionality.SummaryDifference0.1%

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.